MICU1
Basic information
Region (hg38): 10:72367340-72626131
Previous symbols: [ "CBARA1" ]
Links
Phenotypes
GenCC
Source:
- proximal myopathy with extrapyramidal signs (Definitive), mode of inheritance: AR
- proximal myopathy with extrapyramidal signs (Definitive), mode of inheritance: AR
- proximal myopathy with extrapyramidal signs (Strong), mode of inheritance: AR
- proximal myopathy with extrapyramidal signs (Strong), mode of inheritance: AR
- proximal myopathy with extrapyramidal signs (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Myopathy with extrapyramidal signs | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 24336167; 27123478; 29721912 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (253 variants)
- Inborn_genetic_diseases (42 variants)
- Proximal_myopathy_with_extrapyramidal_signs (18 variants)
- not_specified (7 variants)
- MICU1-related_disorder (4 variants)
- Neurodevelopmental_disorder (2 variants)
- Abnormality_of_the_nervous_system (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MICU1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001195518.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 58 | 62 | ||||
| missense | 96 | 100 | ||||
| nonsense | 12 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 11 | |||||
| splice donor/acceptor (+/-2bp) | 11 | 13 | ||||
| Total | 19 | 19 | 98 | 60 | 3 |
Highest pathogenic variant AF is 0.00014505025
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MICU1 | protein_coding | protein_coding | ENST00000361114 | 11 | 258802 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.93e-13 | 0.0593 | 124581 | 0 | 63 | 124644 | 0.000253 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.65 | 174 | 247 | 0.704 | 0.0000130 | 3145 |
| Missense in Polyphen | 31 | 67.052 | 0.46233 | 844 | ||
| Synonymous | 0.839 | 73 | 82.7 | 0.883 | 0.00000402 | 873 |
| Loss of Function | 0.465 | 21 | 23.4 | 0.896 | 0.00000145 | 280 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000459 | 0.000456 |
| Ashkenazi Jewish | 0.000101 | 0.0000994 |
| East Asian | 0.0000556 | 0.0000556 |
| Finnish | 0.0000478 | 0.0000464 |
| European (Non-Finnish) | 0.000286 | 0.000274 |
| Middle Eastern | 0.0000556 | 0.0000556 |
| South Asian | 0.000530 | 0.000523 |
| Other | 0.000194 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of mitochondrial calcium uniporter (MCU) that senses calcium level via its EF-hand domains (PubMed:20693986, PubMed:23101630, PubMed:23747253, PubMed:24313810, PubMed:24332854, PubMed:24503055, PubMed:24560927, PubMed:26341627, PubMed:26903221, PubMed:27099988). MICU1 and MICU2 form a disulfide-linked heterodimer that stimulates and inhibits MCU activity, depending on the concentration of calcium. MICU1 acts both as an activator or inhibitor of mitochondrial calcium uptake (PubMed:26903221). Acts as a gatekeeper of MCU at low concentration of calcium, preventing channel opening (PubMed:26903221). Enhances MCU opening at high calcium concentration, allowing a rapid response of mitochondria to calcium signals generated in the cytoplasm (PubMed:24560927, PubMed:26903221). Regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake (PubMed:22904319). Induces T-helper 1-mediated autoreactivity, which is accompanied by the release of IFNG (PubMed:16002733). {ECO:0000269|PubMed:16002733, ECO:0000269|PubMed:20693986, ECO:0000269|PubMed:22904319, ECO:0000269|PubMed:23101630, ECO:0000269|PubMed:23747253, ECO:0000269|PubMed:24313810, ECO:0000269|PubMed:24332854, ECO:0000269|PubMed:24503055, ECO:0000269|PubMed:24560927, ECO:0000269|PubMed:26341627, ECO:0000269|PubMed:26903221, ECO:0000269|PubMed:27099988}.;
- Disease
- DISEASE: Myopathy with extrapyramidal signs (MPXPS) [MIM:615673]: An autosomal recessive disorder characterized by early-onset proximal muscle weakness with a static course and moderately to grossly elevated serum creatine kinase levels accompanied by learning difficulties. Most patients develop subtle extrapyramidal motor signs that progress to a debilitating disorder of involuntary movement with variable features, including chorea, tremor, dystonic posturing and orofacial dyskinesia. Additional variable features include ataxia, microcephaly, ophthalmoplegia, ptosis, optic atrophy and axonal peripheral neuropathy. {ECO:0000269|PubMed:24336167}. Note=The disease is caused by mutations affecting the gene represented in this entry. The complex phenotype is due to alterations in mitochondrial calcium signaling characterized by increased mitochondrial Ca(2+) load (PubMed:24336167). {ECO:0000269|PubMed:24336167}.; DISEASE: Note=An homozygous partial MICU1 deletion is responsible for a disorder manifesting in childhood with fatigue, lethargy and muscle weakness. The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:27123478}.;
- Pathway
- Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.19
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- N
- hipred_score
- 0.294
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Micu1
- Phenotype
Gene ontology
- Biological process
- mitochondrial calcium ion transmembrane transport;defense response;calcium import into the mitochondrion;protein homooligomerization;mitochondrial calcium ion homeostasis;positive regulation of mitochondrial calcium ion concentration;calcium ion import
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial intermembrane space;integral component of mitochondrial membrane;calcium channel complex;uniplex complex
- Molecular function
- calcium ion binding;protein binding;identical protein binding;protein heterodimerization activity